Abstract
This scoping review sought to map the emerging evidence on use of harm minimization drug treatment programs in criminal justice settings. A search of various data bases including Cochrane Database of Systematic Reviews Medline, ProQuest, SAGE Premier, Scopus, Taylor & Francis Online, and Web of Science yielded eight studies that met inclusion criteria. The available evidence suggests increasing adoption of harm minimization policy oriented programs by countries around the world. Specific programs adopted include needle and syringe exchange, methadone maintenance, buprenorphine maintenance and treatment in lieu of incarceration. Each of these programs has evidence to support their effectiveness in relation to individual harm reduction, disease reduction, increase treatment retention and reduced criminality. This article considers implications of the adoption of harm minimization policies by criminal justice systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anglin, M. D., Nosyk, B., Jaffe, A., Urada, D., & Evans, E. (2013). Offender diversion into substance use disorder treatment: The economic impact of California’s Proposition 36. American Journal of Public Health, 103(6), 1096–1102. doi:10.2105/ajph.2012.301168.
Arksey, H., & O’Malley, L. (2005). Scoping studies: A methodological framework. International Journal of Social Research Methodology, 8(1), 19–32.
Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., et al. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235–248. doi:10.1093/ije/dyt243.
Clark, F. (2013). Global drug policy fuels hepatitis C epidemic, report warns. The Lancet, 381(9881), 1891. doi:10.1016/S0140-6736(13)61145-9.
Duplessy, C., & Reynaud, E. G. (2014). Long-term survey of a syringe-dispensing machine needle exchange program: Answering public concerns. Harm Reduction Journal, 11, 16. doi:10.1186/1477-7517-11-16.
Fu, J. J., Zaller, N. D., Yokell, M. A., Bazazi, A. R., & Rich, J. D. (2013). Forced withdrawal from methadone maintenance therapy in criminal justice settings: A critical treatment barrier in the United States. Journal of Substance Abuse Treatment, 44(5), 502–505. doi:10.1016/j.jsat.2012.10.005.
Gardiner, C., Urada, D., & Anglin, M. D. (2012). Band-Aids and Bullhorns: Why California’s drug policy is failing and what we can do to fix it. Criminal Justice Policy Review, 23(1), 108–135. doi:10.1177/0887403410397185.
Garland, T. S., Bumphus, V. W., & Knox, S. A. (2012). Exploring general and specific attitudes toward drug policies among college students. Criminal Justice Policy Review, 23(1), 3–17. doi:10.1177/0887403410389807.
Golichenko, M., & Sarang, A. (2013). Atmospheric pressure: Russian drug policy as a driver for violations of the UN Convention against Torture and the International Covenant on Economic, Social and Cultural Rights. Health and Human Rights, 15(1), 135–143.
Gordon, M. S., Kinlock, T. W., Couvillion, K. A., Schwartz, R. P., & O’Grady, K. (2012). A Randomized clinical trial of methadone maintenance for prisoners: Prediction of treatment entry and completion in prison. Journal of Offender Rehabilitation, 51(4), 222–238. doi:10.1080/10509674.2011.641075.
Haley, D. F., Golin, C. E., Farel, C. E., Wohl, D. A., Scheyett, A. M., Garrett, J. J., et al. (2014). Multilevel challenges to engagement in HIV care after prison release: A theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry. BMC Public Health, 14, 1253. http://www.bionedcentral.com/1471-2458/14/1253 .
Hampton, A. S., Conner, B. T., Albert, D., Anglin, M. D., Urada, D., & Longshore, D. (2011). Pathways to treatment retention for individuals legally coerced to substance use treatment: The interaction of hope and treatment motivation. Drug and Alcohol Dependence, 118(2–3), 400–407. doi:10.1016/j.drugalcdep.2011.04.022.
Harris, E. E., Jacapraro, J. S., & Rastegar, D. A. (2012). Criminal charges prior to and after initiation of office-based buprenorphine treatment. Substance Abuse Treatment, Prevention, & Policy, 7, 10. doi:10.1186/1747-597X-7-10.
Kidorf, M., King, V. L., Peirce, J., Kolodner, K., & Brooner, R. K. (2011). Benefits of concurrent syringe exchange and substance abuse treatment participation. Journal of Substance Abuse Treatment, 40(3), 265–271. doi:10.1016/j.jsat.2010.11.011.
Lancaster, K., Ritter, A., & Stafford, J. (2013). Public opinion and drug policy in Australia: Engaging the ‘affected community’. Drug & Alcohol Review, 32(1), 60–66. doi:10.1111/j.1465-3362.2012.00497.x.
Luo, W., Wu, Z. Y., Poundstone, K., McGoogan, J. M., Dong, W., Pang, L., et al. (2015). Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. Addiction, 110, 61–67. doi:10.1111/add.12783.
McKeganey, N. (2011). From harm reduction to drug user abstinence: A journey in drug treatment policy. Journal of Substance Use, 16(3), 179–194. doi:10.3109/14659891.2011.580228.
Ritter, A. (2010). Conceptualising ‘balance’ in national drug policy. Drug & Alcohol Review, 29(4), 349–351. doi:10.1111/j.1465-3362.2010.00210.x.
Rosen, D. L., Golin, C. E., Grodensky, C. A., May, J., Bowiling, M., DeVellis, R. F., et al. (2015). Opt-out HIV testing in prison: Informed and voluntary. AIDS Care, 27(5), 545–554. doi:10.1080/09540121.2014.989486.
Stevens, A. (2011). Drug policy, harm and human rights: A rationalist approach. International Journal of Drug Policy, 22(3), 233–238. doi:10.1016/j.drugpo.2011.02.003.
Tourunen, J., Weckroth, A., & Kaskela, T. (2012). Prison-based drug treatment in Finland: History, shifts in policy making and current status. Vol. 29. NAD Publication (pp. 575–588).
Uuskula, A., Des Jarlais, D. C., Kals, M., Ruutel, K., Abel-Ollo, K., Talu, A., et al. (2011). Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health, 11, 517. doi:10.1186/1471-2458-11-517.
Acknowledgments
We wish to acknowledge Dr. Rodd Rothwell for his informative review of an earlier draft of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no known conflict of interest.
Rights and permissions
About this article
Cite this article
Resiak, D., Mpofu, E. & Athanasou, J. Drug Treatment Policy in the Criminal Justice System: A Scoping Literature Review. Am J Crim Just 41, 3–13 (2016). https://doi.org/10.1007/s12103-015-9329-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12103-015-9329-z